Melphalan

FDA Approved: * March 22, 2017
Pharm Company: * ALVOGEN MALTA
Category: Cancer

Melphalan, sold under the trade name Alkeran among others, is a chemotherapy medication used to treat multiple myeloma, ovarian cancer, melanoma, and AL amyloidosis.[1] It is taken as a tablet (by mouth) or by injection into a vein.[1] Common side effects include nausea and bone marrow suppression.[1] Other severe side effects may include anaphylaxis and the development of other cancers.[1] Use during pregnancy may result in harm... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Melphalan Hydrochloride Kit
NDC: 10139-321
Labeler:
Generamedix Inc.
Melphalan Hydrochloride Intravenous Kit
NDC: 25021-221
Labeler:
Sagent Pharmaceuticals
Melphalan HydrochlorideMelphalan Hydrochloride Intravenous Kit
NDC: 25021-258
Labeler:
Sagent Pharmaceuticals
Melphalan HydrochlorideMelphalan Hydrochloride Kit
NDC: 31722-362
Labeler:
Camber Pharmaceuticals, Inc.
Melphalan Hydrochloride Hydrochloride 50 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 42023-149
Labeler:
Par Pharmaceutical, Inc.
Melphalan HydrochlorideMelphalan Hydrochloride Intravenous Kit
NDC: 43598-027
Labeler:
Dr.reddy's Laboratories Inc
Melphalan Hydrochloride Intravenous Kit
NDC: 43598-392
Labeler:
Dr.reddy's Laboratories Inc
Melphalan Hydrochloride Intravenous Kit
NDC: 45963-686
Labeler:
Actavis Pharma, Inc.
Melphalan 2 mg Oral Tablet
NDC: 47781-200
Labeler:
Alvogen Inc.
Melphalan HydrochlorideMelphalan Hydrochloride Kit
NDC: 50742-477
Labeler:
Ingenus Pharmaceuticals, LLC
More Results

Related Brands

Drugs with the same active ingredients